Products On Sale
-
Buy Morphine pills online
Price range: $200.00 through $1,200.00
-
buy norco 10 325
Price range: $200.00 through $3,000.00
-
Hydrocodone 10 325 online
Price range: $200.00 through $3,000.00
-
acxion pills for sale
Price range: $195.00 through $2,400.00
-
buy methadone 10mg online
Price range: $250.00 through $2,400.00
Buy Vyvanse 50mg online
Price range: $280.00 through $2,000.00
Molar mass: 263.378 g/mol
Bioavailability: 96.4%
Formula: C15H25N3O
Excretion: Renal: ~2%
Duration of action: 10–12 h
Onset of action: 2 h
Other names: (2S)-2,6-Diamino-N-, hexanamide; N–L-lysinamide
Has a generic version of Vyvanse been approved?
No. There is currently no therapeutically equivalent version of Vyvanse available in the United States.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vyvanse. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
Related patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug’s development and may include a wide range of claims.
- Abuse-resistant amphetamine compounds
Patent 7,105,486
Issued: September 12, 2006
Inventor(s): Mickle; Travis & Krishnan; Suma & Bishop; Barney & Lauderback; Christopher & Moncrief; James Scott & Oberlender; Rob & Piccariello; Thomas
Assignee(s): New River Pharmaceuticals Inc.
The invention describes compounds, compositions and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.Pediatric exclusivity - Abuse resistant lysine amphetamine compounds
Patent 7,223,735
Issued: May 29, 2007
Inventor(s): Mickle; Travis & Krishnan; Suma & Moncrief; James Scott & Lauderback; Christopher & Bishop; Barney & Oberlender; Rob & Piccariello; Thomas
Assignee(s): New River Pharmaceuticals Inc.
The present invention describes compounds, compositions and methods of using the same comprising lysine covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.
| Dosage | 30 MG, 40 MG, 50 MG, 70 MG |
|---|---|
| Quantity | 30 pills, 60 pills, 90 pills, 100 pills, 150 pills, 180 pills, 200 pills, 250 pills, 300 pills, 500 pills |
Related products
-
Price range: $220.00 through $2,000.00Select options This product has multiple variants. The options may be chosen on the product page
CAS ID: 96332-84-2
Amphetamine aspartate monohydrate: 25% – stimulant; (12.5% levo; 12.5% dextro)
Amphetamine sulfate: 25% – stimulant; (12.5% levo; 12.5% dextro)
Trade name: Adderall, Adderall XR, Mydayis
Dextroamphetamine sulfate: 25% – stimulant; (0% levo; 25% dextro)
Dextroamphetamine saccharate: 25% – stimulant; (0% levo; 25% dextro) -
Price range: $248.00 through $490.00Select options This product has multiple variants. The options may be chosen on the product page
Do not take STILNOX if you:
- Drink alcohol or think that you have alcohol in your blood
- Sleep apnea (a situation where you temporarily stop breathing while you are sleeping)
- Myasthenia gravis (a condition in which the muscles are weak and elastically light)
- severe liver problems
- acid and/or severe lung problems
-
Price range: $210.00 through $1,500.00Select options This product has multiple variants. The options may be chosen on the product page
Elimination half-life: 9–11 hours; pH-dependent: 7–34 hours
Duration of action: IR dosing: 3–6 hours; XR dosing: 8–12 hours
Onset of action: IR dosing: 0.5–1.5 hours; XR dosing: 1.5–2 hours
Metabolism: CYP2D6, DBH, FMO3
Other names: D-Amphetamine
Addiction liability: High
Dependence liability: Moderate -
Price range: $220.00 through $2,000.00Select options This product has multiple variants. The options may be chosen on the product page
CAS ID: 96332-84-2
Amphetamine aspartate monohydrate: 25% – stimulant; (12.5% levo; 12.5% dextro)
Amphetamine sulfate: 25% – stimulant; (12.5% levo; 12.5% dextro)
Trade name: Adderall, Adderall XR, Mydayis
Dextroamphetamine sulfate: 25% – stimulant; (0% levo; 25% dextro)
Dextroamphetamine saccharate: 25% – stimulant; (0% levo; 25% dextro) -
Price range: $126.50 through $506.00Select options This product has multiple variants. The options may be chosen on the product page
PRODUCT DETAILS Clonazepam Action Indications Contraindications Route/Dosage Interactions Lab Test Interferences Adverse Reactions Precautions Patient Care Considerations Administration/Storage Assessment/Interventions Patient/Family Education (kloe-NAY-ze-pam) Klonopin, Rivotril Class: Anticonvulsant/Benzodiazepine Action Potentiates action of GABA, inhibitory neurotransmitter, resulting in increased neuronal inhibition and CNS depression, especially in limbic system and reticular formation. Indications Treatment of Lennox-Gestalt syndrome; management of akinetic …
Reviews
There are no reviews yet.